Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Botta GP"'
Autor:
Botta GP; Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA 92037, United States., Abdelrahim M; Section of GI Oncology, Department of Medical Oncology, Houston Methodist Cancer Center, Houston, TX 77030, United States., Drengler RL; Medical Oncology, The START Center for Cancer Care, San Antonio, TX 78229, United States., Aushev VN; Oncology, Natera, Inc., Austin, TX 78753, United States., Esmail A; Section of GI Oncology, Department of Medical Oncology, Houston Methodist Cancer Center, Houston, TX 77030, United States., Laliotis G; Oncology, Natera, Inc., Austin, TX 78753, United States., Brewer CM; Oncology, Natera, Inc., Austin, TX 78753, United States., George GV; Oncology, Natera, Inc., Austin, TX 78753, United States., Abbate SM; Medical Oncology, The START Center for Cancer Care, San Antonio, TX 78229, United States., Chandana SR; Department of Gastrointestinal Medical Oncology, Cancer & Hematology Centers of Western Michigan, Grand Rapids, MI 49546, United States., Tejani MA; Hematology and Oncology, Advent Health Cancer Institute, Orlando, FL 32804, United States., Malla M; Section of Hematology and Oncology, University of Alabama at Birmingham, AL 35233,United States., Bansal D; Department of Hematology-Oncology, Saint Luke's Cancer Institute, Kansas City, MO 64111, United States., Rivero-Hinojosa S; Oncology, Natera, Inc., Austin, TX 78753, United States., Spickard E; Oncology, Natera, Inc., Austin, TX 78753, United States., McCormick N; Oncology, Natera, Inc., Austin, TX 78753, United States., Cecchini M; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT 06520, United States., Lacy J; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT 06520, United States., Fei N; Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, United States., Kasi PM; Division of Internal Medicine, Department of Oncology/Hematology, Weill Cornell Medicine, New York, NY 10021, United States., Kasi A; Division of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, KS 66160, United States., Dayyani F; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA 92868, United States., Hanna DL; Division of Medical Oncology, Norris Cancer Center, Keck Medicine of USC, Los Angeles, CA 90033, United States., Sharma S; Oncology, Natera, Inc., Austin, TX 78753, United States., Malhotra M; Oncology, Natera, Inc., Austin, TX 78753, United States., Aleshin A; Oncology, Natera, Inc., Austin, TX 78753, United States., Liu MC; Oncology, Natera, Inc., Austin, TX 78753, United States., Jurdi A; Oncology, Natera, Inc., Austin, TX 78753, United States.
Publikováno v:
The oncologist [Oncologist] 2024 Oct 03; Vol. 29 (10), pp. 859-869.
Autor:
Nishizaki D; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla. Electronic address: dnishizaki@health.ucsd.edu., Kurzrock R; MCW Cancer Center and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, USA; WIN Consortium, Paris, France., Miyashita H; Dartmouth Cancer Center, Hematology and Medical Oncology, Lebanon., Adashek JJ; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital, Baltimore., Lee S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla., Nikanjam M; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla., Eskander RN; Center for Personalized Cancer Therapy and Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, Moores Cancer Center, La Jolla., Patel H; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla., Botta GP; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla., Nesline MK; OmniSeq Inc., Buffalo., Pabla S; OmniSeq Inc., Buffalo., Conroy JM; OmniSeq Inc., Buffalo., DePietro P; OmniSeq Inc., Buffalo., Sicklick JK; Division of Surgical Oncology, Department of Surgery, Center for Personalized Cancer Therapy, University of California San Diego, La Jolla, USA., Kato S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla. Electronic address: smkato@health.ucsd.edu.
Publikováno v:
ESMO open [ESMO Open] 2024 Apr; Vol. 9 (4), pp. 102942. Date of Electronic Publication: 2024 Mar 18.
Autor:
Baumgartner JM; Division of Surgical Oncology, Department of Surgery, University of California, San Diego, La Jolla, CA, USA. j1baumgartner@health.ucsd.edu., Botta GP; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Publikováno v:
Journal of gastrointestinal cancer [J Gastrointest Cancer] 2024 Mar; Vol. 55 (1), pp. 41-46. Date of Electronic Publication: 2023 Jul 12.
Autor:
Botta GP; Department of Medicine, Division of Hematology/Oncology, UCSD, La Jolla, California, USA gbotta@ucsd.edu.; Department of Medicine, Division of Cellular and Regenerative Medicine, UCSD, La Jolla, California, USA., Chao J; City of Hope Comprehensive Cancer Center, Duarte, California, USA., Ma H; CARsgen Therapeutics Corp, Houston, Texas, USA., Hahn M; Department of Radiology, University of California San Diego, La Jolla, California, USA., Sierra G; CARsgen Therapeutics Corp, Houston, Texas, USA., Jia J; CARsgen Therapeutics Corp, Houston, Texas, USA., Hendrix AY; CARsgen Therapeutics Corp, Houston, Texas, USA., Nolte Fong JV; CARsgen Therapeutics Corp, Houston, Texas, USA., Ween A; Department of Medicine, Division of Hematology/Oncology, UCSD, La Jolla, California, USA., Vu P; Department of Medicine, Division of Hematology/Oncology, UCSD, La Jolla, California, USA.; Department of Medicine, Division of Cellular and Regenerative Medicine, UCSD, La Jolla, California, USA., Miller A; Department of Medicine, Division of Hematology/Oncology, UCSD, La Jolla, California, USA., Choi M; Department of Medicine, Division of Hematology/Oncology, UCSD, La Jolla, California, USA.; Department of Medicine, Division of Cellular and Regenerative Medicine, UCSD, La Jolla, California, USA., Heyman B; Department of Medicine, Division of Hematology/Oncology, UCSD, La Jolla, California, USA.; Department of Medicine, Division of Cellular and Regenerative Medicine, UCSD, La Jolla, California, USA., Daniels GA; Department of Medicine, Division of Hematology/Oncology, UCSD, La Jolla, California, USA.; Department of Medicine, Division of Cellular and Regenerative Medicine, UCSD, La Jolla, California, USA., Kaufman D; Department of Medicine, Division of Hematology/Oncology, UCSD, La Jolla, California, USA.; Department of Medicine, Division of Cellular and Regenerative Medicine, UCSD, La Jolla, California, USA., Jamieson C; Department of Medicine, Division of Hematology/Oncology, UCSD, La Jolla, California, USA.; Department of Medicine, Division of Cellular and Regenerative Medicine, UCSD, La Jolla, California, USA., Li Z; CARsgen Therapeutics Corp, Houston, Texas, USA., Cohen E; Department of Medicine, Division of Hematology/Oncology, UCSD, La Jolla, California, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Feb 05; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 05.
Autor:
Moeller A; Sharp Rees-Stealy Medical Group San Diego, CA, USA., Kurzrock R; Medical College of Wisconsin Cancer Center and Genomic Sciences and Precision Medicine Center Milwaukee, WI, USA.; Worldwide Innovative Network (WIN) for Personalized Cancer Therapy Paris, France., Botta GP; Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center La Jolla, CA, USA., Adashek JJ; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital Baltimore, MD, USA., Patel H; Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center La Jolla, CA, USA., Lee S; Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center La Jolla, CA, USA., Pabla S; OmniSeq Inc. (Labcorp) Buffalo, NY, USA., Nesline MK; OmniSeq Inc. (Labcorp) Buffalo, NY, USA., Conroy J; OmniSeq Inc. (Labcorp) Buffalo, NY, USA., Sicklick JK; Department of Surgery, Division of Surgical Oncology, UC San Diego School of Medicine San Diego, CA, USA., Kato S; Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center La Jolla, CA, USA.
Publikováno v:
American journal of cancer research [Am J Cancer Res] 2023 Jul 15; Vol. 13 (7), pp. 3257-3265. Date of Electronic Publication: 2023 Jul 15 (Print Publication: 2023).
Autor:
Botta GP; Division of Hematology/Oncology, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, California, USA.; Division of Medical Oncology, Scripps MD Anderson Cancer Center, La Jolla, California, USA.; Scripps Research Translational Institute, La Jolla, California, USA., Huynh TR; Division of Hematology/Oncology, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, California, USA.; Scripps Research Translational Institute, La Jolla, California, USA.; Division of Internal Medicine, Scripps Clinic/Green Hospital, La Jolla, California, USA., Spierling-Bagsic SR; Scripps Whittier Diabetes Institute, Scripps Health, San Diego, California, USA., Agelidis A; Scripps Research Translational Institute, La Jolla, California, USA.; Division of Internal Medicine, Scripps Clinic/Green Hospital, La Jolla, California, USA., Schaffer R; Division of Hepatopancreatobiliary Surgery, Scripps MD Anderson Cancer Center, La Jolla, California, USA., Lin R; Division of Radiation Oncology, Scripps MD Anderson Cancer Center, La Jolla, California, USA., Sigal D; Division of Medical Oncology, Scripps MD Anderson Cancer Center, La Jolla, California, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 7713-7723. Date of Electronic Publication: 2022 Dec 07.
Autor:
Azzi G; HolyCross Medical Group, Ft. Lauderdale, FL, USA., Tavallai M; Natera, Inc., Austin, TX, USA., Aushev VN; Natera, Inc., Austin, TX, USA., Koyen Malashevich A; Natera, Inc., Austin, TX, USA., Botta GP; UC San Diego Health, San Diego, CA, USA., Tejani MA; AdventHealth Cancer Institute, Orlando, FL, USA., Hanna D; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Krinshpun S; Natera, Inc., Austin, TX, USA., Malhotra M; Natera, Inc., Austin, TX, USA., Jurdi A; Natera, Inc., Austin, TX, USA., Aleshin A; Natera, Inc., Austin, TX, USA., Kasi PM; Weill Cornell Medicine, New York, NY, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Mar 17; Vol. 28 (3), pp. 220-229.
Autor:
Shaya J; Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.; Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Kato S; Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA, USA. smkato@ucsd.edu.; Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, La Jolla, CA, USA. smkato@ucsd.edu., Adashek JJ; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins Hospital, Baltimore, MD, USA. jadashek@westernu.edu., Patel H; Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Fanta PT; Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Botta GP; Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Sicklick JK; Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins Hospital, Baltimore, MD, USA.; Department of Surgery, Division of Surgical Oncology, University of California San Diego, UC San Diego Health, San Diego, CA, USA.; Department of Pharmacology, University of California San Diego, UC San Diego Health, San Diego, CA, USA., Kurzrock R; Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, WI, USA.; WIN Consortium, Paris, France.; University of Nebraska, Lincoln, NE, USA.
Publikováno v:
NPJ genomic medicine [NPJ Genom Med] 2023 Jan 20; Vol. 8 (1), pp. 1. Date of Electronic Publication: 2023 Jan 20.
Autor:
Huffman BM; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA., Aushev VN; Natera, Inc, Austin, TX., Budde GL; Natera, Inc, Austin, TX., Chao J; City of Hope Comprehensive Cancer Center, Duarte, CA., Dayyani F; University of California Irvine Chao Family Comprehensive Cancer Center, Orange, CA., Hanna D; Keck Hospital of USC, Los Angeles, CA., Botta GP; UCSD Moores Cancer Center, La Jolla, CA., Catenacci DVT; University of Chicago, Chicago, IL., Maron SB; Memorial Sloan Kettering Cancer Center, New York City, NY., Krinshpun S; Natera, Inc, Austin, TX., Sharma S; Natera, Inc, Austin, TX., George GV; Natera, Inc, Austin, TX., Malhotra M; Natera, Inc, Austin, TX., Jurdi A; Natera, Inc, Austin, TX., Moshkevich S; Natera, Inc, Austin, TX., Aleshin A; Natera, Inc, Austin, TX., Kasi PM; Weill Cornell Medicine, Englander Institute of Precision Medicine, New York Presbyterian Hospital, New York, NY., Klempner SJ; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Dec; Vol. 6, pp. e2200420.
Autor:
Mardinian K; Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, La Jolla, California., Adashek JJ; Department of Internal Medicine, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. jadashek@westernu.edu teoam2011@gmail.com., Botta GP; Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, La Jolla, California., Kato S; Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, La Jolla, California., Kurzrock R; Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, La Jolla, California. jadashek@westernu.edu teoam2011@gmail.com.; WIN Consortium, Paris, France.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Dec; Vol. 20 (12), pp. 2341-2351. Date of Electronic Publication: 2021 Oct 12.